XTL Biopharmaceuticals Ltd ADR (XTLB)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Shlomo S. Shalev
Employees:
8
XTL BIOPHARMACEUTICALS LTD, C/O ALSTON & BIRD LLP, 90 PARK AVENUE, NEW YORK, NY, 10016
972 9 955 7080
-
Formally known as:
- XTL Biopharmaceuticals Ltd.
- XTL Biopharmaceuticals Ltd.
- XTL BIOPHARMACEUTICALS LTD. NEW
- XTL BIOPHARMACEUTICALS LTD. NEW
Date | Ratio |
---|---|
2012-10-04 | 1:10 |
2017-02-10 | 1:5 |
The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. XTL Biopharmaceuticals Ltd. is headquartered in Ramat Gan, Israel.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|